Beam Therapeutics Inc. (NASDAQ:BEAM) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Robert Nelsen Other companies: City Therapeutics, Inc. (Board Director · Since at least Oct 19, 2026); Kardigan, Inc. (Director · Since at least Jun 22, 2026); Metsera, Inc. (Director · Since at least Nov 13, 2025); Prime Medicine, Inc. (Board Member · Since at least Oct 19, 2022); Sana Biotechnology, Inc. (Director · Since at least Feb 3, 2021); Lyell Immunopharma, Inc. (Director · Jun 16, 2021 – Jun 14, 2024 · Past); Revolution Healthcare Acquisition Corp (Director · Mar 17, 2021 – Mar 17, 2021 · Past); Vir Biotechnology, Inc. (Director · Oct 10, 2019 – May 30, 2024 · Past); Karuna Therapeutics Inc (Director · Jun 27, 2019 – Apr 13, 2021 · Past); Unity Biotechnology Inc (Director · May 2, 2018 – Jun 18, 2020 · Past); Denali Therapeutics Inc. (Director · Dec 7, 2017 – Jun 2, 2021 · Past); Syros Pharmaceuticals, Inc. (Director · Jun 29, 2016 – Jun 8, 2017 · Past); Bellerophon Therapeutics Inc (Director · Feb 12, 2015 – Feb 13, 2015 · Past); Juno Therapeutics Inc (Director · Dec 18, 2014 – Mar 5, 2018 · Past); Sage Therapeutics Inc (Director · Jul 17, 2014 – Nov 9, 2015 · Past); Fate Therapeutics, Inc. (Director · Sep 30, 2013 – Oct 4, 2013 · Past); Agios Pharmaceuticals, Inc. (Director · Jul 23, 2013 – Mar 3, 2017 · Past); Kythera Biopharmaceuticals Inc (Director · Oct 10, 2012 – Aug 14, 2014 · Past); NeurogesX Inc (Director · May 1, 2007 – Jun 7, 2012 · Past); Adolor Corp (Director · May 18, 2006 – May 17, 2007 · Past) | Director · Feb 5, 2020 – Mar 31, 2021 · Past |
| John M. Maraganore Other companies: City Therapeutics, Inc. (Executive Chair · Since at least Oct 19, 2026); Takeda Pharmaceutical Co. Ltd. (Director · Since at least Mar 18, 2026); Hemab Therapeutics Holdings, Inc. (Director · Since at least Jan 29, 2026); Rapport Therapeutics, Inc. (Venture Partner, ARCH Venture Partners and Atlas Ventures · Since at least Jun 6, 2024); Kymera Therapeutics, Inc. (Director · Since at least Jan 17, 2022); Alnylam Pharmaceuticals, Inc. (Director · Since at least May 12, 2006); Instil Bio, Inc. (Director · Jun 11, 2025 – Nov 4, 2026 · Past); ProKidney Corp. (Director · Jul 11, 2022 – Jun 29, 2023 · Past); Agios Pharmaceuticals, Inc. (Director · Jul 23, 2013 – Dec 31, 2022 · Past); Bluebird bio Inc (Director · Jun 18, 2013 – Sep 14, 2017 · Past); Regulus Therapeutics Inc (Director · Oct 4, 2012 – Oct 10, 2012 · Past) | Board Member · Since at least Nov 5, 2021 |
| Kristina Burow Other companies: Kardigan, Inc. (Director · Since at least Jun 22, 2026); Metsera, Inc. (Director · Since at least Jan 30, 2025); Boundless Bio, Inc. (Director · Since at least Mar 27, 2024); Neumora Therapeutics, Inc. (Director · Since at least Sep 14, 2023); Scholar Rock Holding Corporation (Director · Since at least May 23, 2018); Metacrine Inc (Director · Sep 15, 2020 – May 24, 2021 · Past); Vir Biotechnology, Inc. (Director · Oct 10, 2019 – May 21, 2020 · Past); Gossamer Bio, Inc. (Director · Feb 7, 2019 – Jun 8, 2023 · Past); Unity Biotechnology Inc (Director · May 2, 2018 – Jun 24, 2021 · Past); Receptos Inc (Director · Aug 25, 2015 – Aug 25, 2015 · Past) | Director · Feb 5, 2020 – Jun 6, 2023 · Past |
| Graham Cooper Other companies: Kezar Life Sciences, Inc. (Director · Since at least Jun 20, 2018); Nuvation Bio Inc. (Director · Jun 30, 2020 – Feb 10, 2021 · Past); Applied Molecular Transport Inc (Director · Jun 4, 2020 – Jan 27, 2022 · Past); Unity Biotechnology Inc (Director · May 2, 2018 – Jun 24, 2021 · Past); Assembly Biosciences, Inc. (See Remarks · Mar 8, 2018 – Mar 29, 2019 · Past); Eiger Biopharmaceuticals Inc (Director · Jan 29, 2014 – Jun 4, 2015 · Past); Receptos Inc (Chief Financial Officer · May 8, 2013 – Aug 27, 2015 · Past); Geron Corporation (EVP, Bus Dev & CFO · Jan 5, 2012 – May 17, 2012 · Past); Orexigen Therapeutics Inc (CFO and Treasurer · Apr 25, 2007 – Jan 18, 2011 · Past) | Director · Since at least Feb 5, 2020 |
| Carole Ho Other companies: Eli Lilly and Company (Executive Vice President and President, Lilly Neuroscience · Since at least Dec 31, 2025); Royalty Pharma plc (Board Member · Since at least Jul 17, 2025); Denali Therapeutics Inc. (Chief Medical Officer · Since at least Dec 7, 2017); NGM Biopharmaceuticals Inc (Director · Jun 5, 2020 – Apr 5, 2024 · Past) | Director · Since at least Feb 5, 2020 |
| Christi Shaw Other companies: Kyverna Therapeutics, Inc. (Executive Chairperson · Since at least Sep 16, 2024); Avantor, Inc. (Director · May 16, 2019 – May 11, 2023 · Past); Eli Lilly and Company (SVP and Pres., Lilly Bio-Meds · Apr 3, 2017 – May 3, 2019 · Past) | Board Member · Since at least Dec 13, 2023 |
| Kathleen E Walsh Other companies: LifeMD, Inc. (Director · Dec 15, 2022 – Dec 15, 2022 · Past); WellCare Health Plans Inc (Director · May 23, 2018 – Jan 23, 2020 · Past); Imprivata Inc (Director · Feb 24, 2016 – Sep 16, 2016 · Past) | Director · Since at least Jan 10, 2021 |
| Sravan Emany Other companies: Kyverna Therapeutics, Inc. (Independent Director · Since at least Feb 24, 2026); Assertio Holdings, Inc. (Director · Since at least Nov 14, 2023); Ironwood Pharmaceuticals, Inc. (SVP, COO and CFO · Dec 6, 2021 – Nov 18, 2024 · Past) | Chief Financial Officer · Since at least Dec 19, 2024 |
| Chirfi Guindo Other companies: Merck & Company, Inc. (EVP, Access, Policy & Comms · Since at least Jul 1, 2022); Biogen Inc. (Head of Glob Prod Strat & Com · Nov 7, 2017 – Feb 18, 2022 · Past) | Board Member · Since at least Dec 2, 2024 |
| Terry-Ann Burrell Other companies: Rapport Therapeutics, Inc. (Director · Jun 6, 2024 – Jun 6, 2024 · Past); Recursion Pharmaceuticals, Inc. (Director · Apr 15, 2021 – Jul 1, 2024 · Past) | Chief Financial Officer · Feb 5, 2020 – Apr 26, 2024 · Past |
| John Evans Other companies: Verve Therapeutics Inc (Director · Jun 16, 2021 – Jun 9, 2022 · Past) | Chief Executive Officer and Board Member · Since at least Feb 5, 2020 |
| Amy Simon | Chief Medical Officer · Since at least Mar 16, 2023 |
| Bethany Cavanagh | Senior Vice President of Finance, Treasurer and Principal Accounting Officer · Since at least Aug 9, 2024 |
| Christine Bellon | Chief Legal Officer · Since at least Mar 16, 2023 |
| Eric Foster | Chief Commercial Officer · Since Sep 1, 2026 |
| Giuseppe Ciaramella | President · Since at least Feb 5, 2020 |
| Gopi Shanker | Chief Scientific Officer · Since at least Jun 18, 2026 |
| Kate Walsh | Board Member · Since at least Nov 4, 2026 |
| Manmohan Singh | Chief Technology Officer · Since at least Nov 5, 2026 |
| Mark Fishman | Independent Lead Director · Since at least Feb 5, 2020 |
| Stephen C Knight | Director · Feb 5, 2020 – Feb 5, 2020 · Past |
| Susan O’Connor | Chief Human Resources Officer · Since at least Nov 5, 2026 |